DEUTSCHE BANK AG\ - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$31,536,000
+33.3%
183,241
-2.8%
0.02%
+36.4%
Q2 2021$23,651,000
+41.7%
188,472
+53.2%
0.01%
+22.2%
Q1 2021$16,689,000
+34.9%
123,060
+27.2%
0.01%
+12.5%
Q4 2020$12,375,000
+13.7%
96,723
-0.0%
0.01%
+14.3%
Q3 2020$10,886,000
+3.6%
96,745
-12.2%
0.01%
-12.5%
Q2 2020$10,504,000
-15.2%
110,242
-20.0%
0.01%
-27.3%
Q1 2020$12,389,000
+95.4%
137,856
+15.3%
0.01%
+175.0%
Q4 2019$6,340,000
+37.3%
119,591
+2.2%
0.00%
+33.3%
Q3 2019$4,619,000
-11.4%
116,969
-7.9%
0.00%0.0%
Q2 2019$5,213,000
-4.6%
126,987
+8.1%
0.00%0.0%
Q1 2019$5,467,000
-20.2%
117,465
-25.3%
0.00%
-40.0%
Q4 2018$6,850,000
-80.8%
157,347
-74.8%
0.01%
-50.0%
Q3 2018$35,718,000
+23.3%
624,167
+4.5%
0.01%
+25.0%
Q2 2018$28,968,000
+40.0%
597,101
+12.8%
0.01%
-20.0%
Q1 2018$20,697,000
-8.7%
529,419
-0.9%
0.01%
-33.3%
Q4 2017$22,671,000
-34.4%
534,257
-42.3%
0.02%
-37.5%
Q3 2017$34,556,000
+192.3%
925,992
+137.9%
0.02%
+200.0%
Q2 2017$11,824,000
+29.1%
389,162
+12.5%
0.01%
+14.3%
Q1 2017$9,156,000
+27.3%
345,936
+22.7%
0.01%
+16.7%
Q4 2016$7,192,000
-37.7%
281,887
-11.6%
0.01%
-25.0%
Q3 2016$11,543,000
-9.0%
319,033
-14.5%
0.01%
-11.1%
Q2 2016$12,680,000
+54.7%
373,247
+20.2%
0.01%
+50.0%
Q1 2016$8,195,000
-0.0%
310,622
+84.7%
0.01%0.0%
Q4 2015$8,198,000
+221.1%
168,175
+63.9%
0.01%
+200.0%
Q3 2015$2,553,000
-29.9%
102,595
-10.9%
0.00%0.0%
Q2 2015$3,641,000
-1.8%
115,116
+18.1%
0.00%0.0%
Q1 2015$3,709,000
+9.9%
97,485
+12.5%
0.00%0.0%
Q4 2014$3,374,000
+17.7%
86,661
-8.6%
0.00%0.0%
Q3 2014$2,866,000
+43.2%
94,841
+60.9%
0.00%
+100.0%
Q2 2014$2,001,000
+1787.7%
58,947
+1805.2%
0.00%
Q1 2014$106,000
+10500.0%
3,094
+6775.6%
0.00%
Q4 2013$1,000450.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders